Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors

Abel Romero-Corral, Virend Somers, Josef Korinek, Justo Sierra-Johnson, Randal J. Thomas, Thomas G. Allison, Francisco Lopez-Jimenez

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) remains as the first cause of death worldwide. Scientific community works everyday trying to ameliorate this burden. Only in the year 2004 around 2,790 publications about the therapeutic use of antihypertensive agents can be found in MEDLINE. Despite this overwhelming effort and information, only a relatively short number of manuscripts have a real impact in clinical practice. For the busy clinician, it becomes almost impossible to screen and be updated with the landmark publications. The purpose of this article is to provide concise information related to prevention of CVD. We reviewed publications in the past 5 years regarding cardiovascular risk factors with special attention to dyslipidemia, hypertension, diabetes, smoking cessation and obesity, discussing some new findings and treatments. We also discuss obstructive sleep apnea (OSA) as a recently identified cardiovascular risk factor, and provide a general overview about its pathophysiology and treatment.

Original languageEnglish (US)
Pages (from-to)237-244
Number of pages8
JournalRevista de Investigacion Clinica
Volume58
Issue number3
StatePublished - May 2006

Fingerprint

Disease Management
Publications
Heart Diseases
Cardiovascular Diseases
Manuscripts
Therapeutic Uses
Obstructive Sleep Apnea
Smoking Cessation
Dyslipidemias
MEDLINE
Antihypertensive Agents
Cause of Death
Obesity
Hypertension

Keywords

  • Atherosclerosis
  • Cardiovascular disease
  • Diabetes
  • Dyslipidemia
  • Hypertension
  • Obesity
  • Obstructive sleep apnea
  • Prevention
  • Risk factors
  • Smoking cessation
  • Update

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Update in prevention of atherosclerotic heart disease : Management of major cardiovascular risk factors. / Romero-Corral, Abel; Somers, Virend; Korinek, Josef; Sierra-Johnson, Justo; Thomas, Randal J.; Allison, Thomas G.; Lopez-Jimenez, Francisco.

In: Revista de Investigacion Clinica, Vol. 58, No. 3, 05.2006, p. 237-244.

Research output: Contribution to journalArticle

Romero-Corral, A, Somers, V, Korinek, J, Sierra-Johnson, J, Thomas, RJ, Allison, TG & Lopez-Jimenez, F 2006, 'Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors', Revista de Investigacion Clinica, vol. 58, no. 3, pp. 237-244.
Romero-Corral A, Somers V, Korinek J, Sierra-Johnson J, Thomas RJ, Allison TG et al. Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors. Revista de Investigacion Clinica. 2006 May;58(3):237-244.
Romero-Corral, Abel ; Somers, Virend ; Korinek, Josef ; Sierra-Johnson, Justo ; Thomas, Randal J. ; Allison, Thomas G. ; Lopez-Jimenez, Francisco. / Update in prevention of atherosclerotic heart disease : Management of major cardiovascular risk factors. In: Revista de Investigacion Clinica. 2006 ; Vol. 58, No. 3. pp. 237-244.
@article{c862e5b74210413188ea6a33ea722102,
title = "Update in prevention of atherosclerotic heart disease: Management of major cardiovascular risk factors",
abstract = "Cardiovascular disease (CVD) remains as the first cause of death worldwide. Scientific community works everyday trying to ameliorate this burden. Only in the year 2004 around 2,790 publications about the therapeutic use of antihypertensive agents can be found in MEDLINE. Despite this overwhelming effort and information, only a relatively short number of manuscripts have a real impact in clinical practice. For the busy clinician, it becomes almost impossible to screen and be updated with the landmark publications. The purpose of this article is to provide concise information related to prevention of CVD. We reviewed publications in the past 5 years regarding cardiovascular risk factors with special attention to dyslipidemia, hypertension, diabetes, smoking cessation and obesity, discussing some new findings and treatments. We also discuss obstructive sleep apnea (OSA) as a recently identified cardiovascular risk factor, and provide a general overview about its pathophysiology and treatment.",
keywords = "Atherosclerosis, Cardiovascular disease, Diabetes, Dyslipidemia, Hypertension, Obesity, Obstructive sleep apnea, Prevention, Risk factors, Smoking cessation, Update",
author = "Abel Romero-Corral and Virend Somers and Josef Korinek and Justo Sierra-Johnson and Thomas, {Randal J.} and Allison, {Thomas G.} and Francisco Lopez-Jimenez",
year = "2006",
month = "5",
language = "English (US)",
volume = "58",
pages = "237--244",
journal = "Revista de Investigacion Clinica",
issn = "0034-8376",
publisher = "Instituto Nacional de la Nutricion Salvador Zubiran",
number = "3",

}

TY - JOUR

T1 - Update in prevention of atherosclerotic heart disease

T2 - Management of major cardiovascular risk factors

AU - Romero-Corral, Abel

AU - Somers, Virend

AU - Korinek, Josef

AU - Sierra-Johnson, Justo

AU - Thomas, Randal J.

AU - Allison, Thomas G.

AU - Lopez-Jimenez, Francisco

PY - 2006/5

Y1 - 2006/5

N2 - Cardiovascular disease (CVD) remains as the first cause of death worldwide. Scientific community works everyday trying to ameliorate this burden. Only in the year 2004 around 2,790 publications about the therapeutic use of antihypertensive agents can be found in MEDLINE. Despite this overwhelming effort and information, only a relatively short number of manuscripts have a real impact in clinical practice. For the busy clinician, it becomes almost impossible to screen and be updated with the landmark publications. The purpose of this article is to provide concise information related to prevention of CVD. We reviewed publications in the past 5 years regarding cardiovascular risk factors with special attention to dyslipidemia, hypertension, diabetes, smoking cessation and obesity, discussing some new findings and treatments. We also discuss obstructive sleep apnea (OSA) as a recently identified cardiovascular risk factor, and provide a general overview about its pathophysiology and treatment.

AB - Cardiovascular disease (CVD) remains as the first cause of death worldwide. Scientific community works everyday trying to ameliorate this burden. Only in the year 2004 around 2,790 publications about the therapeutic use of antihypertensive agents can be found in MEDLINE. Despite this overwhelming effort and information, only a relatively short number of manuscripts have a real impact in clinical practice. For the busy clinician, it becomes almost impossible to screen and be updated with the landmark publications. The purpose of this article is to provide concise information related to prevention of CVD. We reviewed publications in the past 5 years regarding cardiovascular risk factors with special attention to dyslipidemia, hypertension, diabetes, smoking cessation and obesity, discussing some new findings and treatments. We also discuss obstructive sleep apnea (OSA) as a recently identified cardiovascular risk factor, and provide a general overview about its pathophysiology and treatment.

KW - Atherosclerosis

KW - Cardiovascular disease

KW - Diabetes

KW - Dyslipidemia

KW - Hypertension

KW - Obesity

KW - Obstructive sleep apnea

KW - Prevention

KW - Risk factors

KW - Smoking cessation

KW - Update

UR - http://www.scopus.com/inward/record.url?scp=33748305700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748305700&partnerID=8YFLogxK

M3 - Article

C2 - 16958300

AN - SCOPUS:33748305700

VL - 58

SP - 237

EP - 244

JO - Revista de Investigacion Clinica

JF - Revista de Investigacion Clinica

SN - 0034-8376

IS - 3

ER -